文献速递糖尿病

血清尿调节素与老年人2型糖尿病相关但不预测其发生:KORA F4/FF4研究

Serum Uromodulin Is Associated With But Does Not Predict Type 2 Diabetes in Elderly KORA F4/FF4 Study Participants.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

基于KORA F4/FF4人群研究,在1119名62至81岁参与者中分析血清尿调节素与2型糖尿病(T2D)的关联,平均随访6.5年后复评635人。血清尿调节素在男性中与T2D独立负相关,但在男女中均不能预测未来T2D发生。

要点

  • 血清尿调节素在男性中与T2D独立负相关,校正eGFR后仍显著。
  • 血清尿调节素与糖尿病前期无关,且不能预测男女未来T2D发生。
  • 该指标或反映与T2D相关的肾脏功能状态,但无预测价值。

核心结论

  • 血清尿调节素在男性中与T2D独立相关,但不是未来T2D发生的预测因子。

研究设计与样本

  • 基于人群的KORA F4/FF4研究,纳入1119名62至81岁参与者,平均随访6.5±0.3年,复评635人。
  • 基线及随访时通过口服葡萄糖耐量试验确定糖耐量状态(已知T2D者除外)。

主要发现

  • 粗略分析及校正年龄和BMI后,血清尿调节素在男性和女性中均与T2D负相关(男性P<0.001,女性P<0.05)。
  • 进一步校正eGFR后,血清尿调节素在男性中仍与T2D显著负相关(P<0.001),在女性中不显著。
  • 多变量校正后,血清尿调节素与糖尿病前期无关。
  • 随访6.5±0.3年后,血清尿调节素在男性和女性中均不能预测T2D发生。

临床怎么用

  • 血清尿调节素不宜作为T2D风险预测工具。
  • 在男性中解读血清尿调节素与T2D关联时需考虑肾功能(eGFR)影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Serum uromodulin has recently emerged as promising biomarker for kidney function and was suggested to be associated with type 2 diabetes (T2D) in patients with coronary heart disease. Here, we analyzed the association of serum uromodulin with T2D in the population-based KORA F4/FF4 study. METHODS: In 1119 participants of the KORA F4 study aged 62 to 81 years, serum uromodulin was measured, and the association of serum uromodulin with T2D was assessed using logistic and linear regression models stratified for sex. After a mean follow-up time of 6.5 years, 635 participants where re-evaluated. Glucose tolerance status was determined by oral glucose tolerance test at baseline and at the follow-up examination except in cases of known T2D. RESULTS: Serum uromodulin was inversely associated with T2D in the crude analysis and after adjustment for age and body mass index in men (P < 0.001) and in women (P < 0.05). After further adjustment for estimated glomerular filtration rate, serum uromodulin was significantly inversely associated with T2D in men (P < 0.001) but not in women. Serum uromodulin was not associated with prediabetes after multivariate adjustment and did not predict T2D in men or in women after the follow-up time of 6.5 ± 0.3 years. CONCLUSIONS: In participants of the KORA F4 study, serum uromodulin is independently associated with T2D in men but is not a predictor of future development of T2D.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Then C, Then H, Meisinger C, et al. Serum Uromodulin Is Associated With But Does Not Predict Type 2 Diabetes in Elderly KORA F4/FF4 Study Participants. J Clin Endocrinol Metab. 2019. PMID: 30892596. doi:10.1210/jc.2018-02557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。